San Diego, CA -- (SBWIRE) -- 11/03/2015 -- A shareholder in NYSE:BMR shares, filed a lawsuit against acquisition of Biomed Realty Trust Inc by affiliates of Blackstone Real Estate Partners VIII for $23.75 per share.

Investors who purchased shares of Biomed Realty Trust Inc (NYSE:BMR) and currently hold any of those NYSE:BMR shares have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation or call 858-779-1554.

The plaintiff alleges that the defendants breached their fiduciary duties owed to NYSE:BMR stockholders by agreeing to sell Biomed Realty Trust Inc. too cheaply via an unfair process to affiliates of Blackstone Real Estate Partners VIII.

On October 8, 2015, Biomed Realty Trust Inc (NYSE:BMR) announced that it has entered into an agreement with affiliates of Blackstone Real Estate Partners VIII, under which Blackstone will acquire all outstanding shares of common stock of Biomed Realty Trust Inc (NYSE:BMR) for $23.75 per share in an all-cash transaction valued at $8 billion.

However, the plaintiff claims that the proposed consideration NYSE:BMR shareholders will receive is grossly inadequate and undervalues Biomed Realty Trust Inc. Indeed, at least one analyst has set the high target price for NYSE:BMR shares at $26.00 per share. Furthermore, Biomed Realty Trust Inc reported that its annual Total Revenue rose from $637.31 million in 2013 to $674.61 million in 2014 and that its respective Net Income increased from $46.64 million to $193.78 million. Shares of Biomed Realty Trust Inc (NYSE:BMR) reached as high as $24.68 per share in January 2015. In addition, the plaintiff claims that the process is also unfair to NYSE:BMR stockholders.

Those who are current investors in Biomed Realty Trust Inc shares have certain options and should contact the Shareholders Foundation.

Contact:
Shareholders Foundation, Inc.
Michael Daniels
3111 Camino Del Rio North - Suite 423
92108 San Diego
Phone: +1-(858)-779-1554
Fax: +1-(858)-605-5739
mail@shareholdersfoundation.com